Lv31
350 积分 2023-10-25 加入
Burden of neurological disorders in China and its provinces, 1990–2021: Findings from the global burden of disease study 2021
4小时前
已完结
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
8天前
已完结
Netrin-1: An emerging player in inflammatory diseases
19天前
已完结
UNC5 dependence receptor family in human cancer: A controllable double-edged sword
21天前
已完结
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor
1个月前
已完结
Allogeneic Hematopoietic Cell Transplantation with Briquilimab (JSP191) Anti-CD117 Antibody-Based Nonmyeloablative Conditioning for GATA2 Deficiency
1个月前
已完结
Neuroinflammation in Alzheimer disease
2个月前
已完结
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
2个月前
已完结
A phase I dose escalation, safety and pharmacokinetic (PK) study of AZD5312 (IONIS-ARRx), a first-in-class Generation 2.5 antisense oligonucleotide targeting the androgen receptor (AR)
2个月前
已完结
Treatment of chronic inducible urticaria
3个月前
已完结
皖公网安备34019202002308
